Effects of Belapectin, an Inhibitor of Galectin-3, in Patients With Nonalcoholic Steatohepatitis With Cirrhosis and Portal Hypertension-Reference-Cited by-同舟云学术

Effects of Belapectin, an Inhibitor of Galectin-3, in Patients With Nonalcoholic Steatohepatitis With Cirrhosis and Portal Hypertension

Published:2020-04 Issue:5 Volume:158 Page:1334-1345.e5
ISSN:0016-5085
Container-title:Gastroenterology
language:en
Short-container-title:Gastroenterology

Author:

Chalasani Naga,Abdelmalek Manal F.,Garcia-Tsao Guadalupe,Vuppalanchi Raj^ORCID,Alkhouri Naim,Rinella Mary^ORCID,Noureddin Mazen,Pyko Maxmillan,Shiffman Mitchell,Sanyal Arun,Allgood Adam,Shlevin Harold,Horton Rex^ORCID,Zomer Eliezer,Irish William,Goodman Zachary,Harrison Stephen A.,Traber Peter G.,Abdelmalek Manal,Balart Luis,Borg Brian,Chalasani Naga,Charlton Michael,Conjeevaram Hari,Fuchs Michael,Ghalib Reem,Gholam Pierre,Halegoua-De Marzio Dina,Harrison Stephen,Jue Christopher,Kemmer Nyingi,Kowdley Kris,Lai Michelle,Lawitz Eric,Loomba Rohit,Noureddin Mazen,Paredes Angelo,Rinella Mary,Rockey Don,Rodriguez Miguel,Rubin Raymond,Ryan Michael,Sanyal Arun,Scanga Andrew,Sepe Thomas,Shiffman Mitchell,Shiffman Mitchell,Tetri Brent,Thuluvath Paul,Torres Dawn,Vierling John,Wattacheril Julia,Weiland Amanda,Zogg Donald

Publisher

Elsevier BV

Subject

Gastroenterology,Hepatology

Reference28 articles.

1. The diagnosis and management of nonalcoholic fatty liver disease: practice guidance from the American Association for the Study of Liver Diseases;Chalasani;Hepatology,2018

2. Projected increase in obesity and non-alcoholic-steatohepatitis-related liver transplantation waitlist additions in the United States;Parikh;Hepatology,2019

3. NASH leading cause of liver transplant in women: updated analysis of indications for liver transplant and ethnic and gender variances;Noureddin;Am J Gastroenterol,2018

4. Hepatic venous pressure gradient predicts clinical decompensation in patients with compensated cirrhosis;Ripoll;Gastroenterology,2007

5. Lowering portal pressure improves outcomes of patients with cirrhosis, with or without ascites: a meta-analysis;Turco;Clin Gastroenterol Hepatol,2020

Cited by 233 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Decreasing the burden of non-alcoholic fatty liver disease: From therapeutic targets to drug discovery opportunities;European Journal of Medicinal Chemistry;2024-11

2. Understanding Macrophage Complexity in Metabolic Dysfunction-Associated Steatotic Liver Disease: Transitioning from the M1/M2 Paradigm to Spatial Dynamics;Livers;2024-09-13

3. Breakthrough in the Treatment of Metabolic Associated Steatotic Liver Disease: Is it all over?;Digestive and Liver Disease;2024-09

4. Current and experimental pharmacotherapy for the management of non-alcoholic fatty liver disease;Hormones;2024-08-07

5. Unravelling the complexities of non-alcoholic steatohepatitis: The role of metabolism, transporters, and herb-drug interactions;Life Sciences;2024-08